These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35728968)

  • 21. Pharmaceutical care of rituximab in the treatment of children with refractory anti-NMDAR encephalitis: A case report.
    Wu H; Xu X; Ding Q; Zhu S; Zheng Q; Ding S; Li J; Zhao H
    Medicine (Baltimore); 2023 Feb; 102(5):e32843. PubMed ID: 36749271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments.
    Massa F; Franciotta D; Grisanti S; Roccatagliata L; Morbelli S; Beltramini S; Uccelli A; Schenone A; Benedetti L
    Neurol Sci; 2022 Nov; 43(11):6441-6447. PubMed ID: 35953578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Teratoma Removal, Steroid, IVIG, Rituximab and Tocilizumab (T-SIRT) in Anti-NMDAR Encephalitis.
    Lee WJ; Lee ST; Shin YW; Lee HS; Shin HR; Kim DY; Kim S; Lim JA; Moon J; Park KI; Kim HS; Chu K; Lee SK
    Neurotherapeutics; 2021 Jan; 18(1):474-487. PubMed ID: 32880854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of NMDAR encephalitis treated in the third trimester - novel arterial spin labeling findings and a review of literature.
    Jung KO; Moon HJ
    J Neuroimmunol; 2020 Jun; 343():577235. PubMed ID: 32279021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-N-Methyl-d-Aspartate receptor (NMDAR) encephalitis during pregnancy: Clinical analysis of reported cases.
    Shi YC; Chen XJ; Zhang HM; Wang Z; Du DY
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):315-319. PubMed ID: 28600040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Refractory anti-NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review.
    Lazzarin SM; Vabanesi M; Cecchetti G; Fazio R; Fanelli GF; Volonté MA; Genchi A; Giordano A; Martinelli V; Colombo S; Beccaria P; Mucci M; Peccatori J; Filippi M; Minicucci F
    J Neurol; 2020 Aug; 267(8):2462-2468. PubMed ID: 32535682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy outcome in anti-N-methyl-D-aspartate receptor encephalitis.
    Magley J; Towner D; Taché V; Apperson ML
    Obstet Gynecol; 2012 Aug; 120(2 Pt 2):480-483. PubMed ID: 22825272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma cell depletion with bortezomib in the treatment of refractory N-methyl-d-aspartate (NMDA) receptor antibody encephalitis. Rational developments in neuroimmunological treatment.
    Keddie S; Crisp SJ; Blackaby J; Cox A; Coles A; Hart M; Church AJ; Vincent A; Zandi M; Lunn MP
    Eur J Neurol; 2018 Nov; 25(11):1384-1388. PubMed ID: 30035842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy and safety of cyclophosphamide as a sequential immunotherapy drug for anti-N-methyl-D-aspartate receptor encephalitis in children].
    Zhu WW; Liao WP; Yi YH; Song XW
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jun; 19(6):668-671. PubMed ID: 28606234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care.
    de Montmollin E; Demeret S; Brulé N; Conrad M; Dailler F; Lerolle N; Navellou JC; Schwebel C; Alves M; Cour M; Engrand N; Tonnelier JM; Maury E; Ruckly S; Picard G; Rogemond V; Magalhaes É; Sharshar T; Timsit JF; Honnorat J; Sonneville R;
    Am J Respir Crit Care Med; 2017 Feb; 195(4):491-499. PubMed ID: 27552490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Infant Born to a Mother With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.
    Chourasia N; Watkins MW; Lankford JE; Kass JS; Kamdar A
    Pediatr Neurol; 2018 Feb; 79():65-68. PubMed ID: 29310908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bortezomib for treatment of anti-NMDA receptor encephalitis in a pediatric patient refractory to conventional therapy.
    Simmons ML; Perez KA
    Am J Health Syst Pharm; 2021 Feb; 78(5):395-400. PubMed ID: 33547464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower dosages of rituximab used successfully in the treatment of anti-NMDA receptor encephalitis without tumour.
    Wang BJ; Wang CJ; Zeng ZL; Yang Y; Guo SG
    J Neurol Sci; 2017 Jun; 377():127-132. PubMed ID: 28477682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary embolism complicated the course of anti-N-methyl-D aspartate receptor encephalitis in a pediatric intensive care unit setting: a case report.
    Ekinci F; Yildizdas D; Horoz OO; Yontem A; Gul Mert G
    Postgrad Med; 2021 Jan; 133(1):102-107. PubMed ID: 32703058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended Clinical Spectrum of Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Children: A Case Series.
    Goenka A; Jain V; Nariai H; Spiro A; Steinschneider M
    Pediatr Neurol; 2017 Jul; 72():51-55. PubMed ID: 28506503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions.
    Kuppuswamy PS; Takala CR; Sola CL
    Gen Hosp Psychiatry; 2014; 36(4):388-91. PubMed ID: 24731834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HSV encephalitis triggered anti-NMDAR encephalitis: a case report.
    Hu S; Lan T; Bai R; Jiang S; Cai J; Ren L
    Neurol Sci; 2021 Mar; 42(3):857-861. PubMed ID: 33420613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis in a young Lebanese girl.
    Safadieh L; Dabbagh O
    J Child Neurol; 2013 Oct; 28(10):1222-5. PubMed ID: 22992990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term and Strong Immunotherapy to Treat Anti-N-Methyl- D-Aspartate Receptor Encephalitis with Refractory Status Epilepticus.
    Lee LH; Lu CJ
    Acta Neurol Taiwan; 2016 Sep; 25(3):99-103. PubMed ID: 27854088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case Report: Overlapping Multiple Sclerosis With Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Report and Review of Literature.
    Huang Y; Wang Q; Zeng S; Zhang Y; Zou L; Fu X; Xu Q
    Front Immunol; 2020; 11():595417. PubMed ID: 33362777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.